131 related articles for article (PubMed ID: 36398480)
1. Development of a novel head and neck squamous cell carcinoma prognostic signature by bulk/single-cell sequencing data integration.
Dai Y; Li J; Huang R; Yao Q; Shi Y; Guo S; Wang Y; Cheng J
Oral Dis; 2024 Mar; 30(2):128-139. PubMed ID: 36398480
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
Dai Y; Wang Z; Yan E; Li J; Ge H; Xiao N; Cheng J; Diao P
Head Neck; 2022 Oct; 44(10):2171-2180. PubMed ID: 35726502
[TBL] [Abstract][Full Text] [Related]
3. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
4. Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts.
Xue H; Sun Q; Zhang H; Huang H; Xue H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):156. PubMed ID: 38526631
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model based on Scissor
Tian G; Zhang J; Bao Y; Li Q; Hou J
Cell Signal; 2024 Feb; 114():110984. PubMed ID: 38029947
[TBL] [Abstract][Full Text] [Related]
6. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel prognostic signature derived from essential genes in head and neck squamous cell carcinoma.
Dai Y; Yao Q; Wang Z; Diao P; Wang D; Yan E; Wang Y
J Oral Pathol Med; 2023 Aug; 52(7):610-618. PubMed ID: 37098725
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel prognostic signature derived from enhancer RNA-regulated genes in head neck squamous cell carcinoma.
Diao P; Huang R; Shi Y; Yao Q; Dai Y; Yuan H; Wang Y; Cheng J
Head Neck; 2023 Apr; 45(4):900-912. PubMed ID: 36786387
[TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
12. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.
Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y
Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177
[TBL] [Abstract][Full Text] [Related]
14. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
15. A predictive model of immune infiltration and prognosis of head and neck squamous cell carcinoma based on cell adhesion-related genes: including molecular biological validation.
Liu Y; Wu Z; Fu Z; Han Y; Wang J; Zhang Y; Liang B; Tao Y; Zhang Y; Shen C; Xu Y; Yin S; Chen B; Liu Y; Pan H; Liang Z; Wu K
Front Immunol; 2023; 14():1190678. PubMed ID: 37691922
[TBL] [Abstract][Full Text] [Related]
16. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
17. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
18. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
[TBL] [Abstract][Full Text] [Related]
19. A nomogram based on a gene signature for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Yang B; Fu L; Xu S; Xiao J; Li Z; Liu Y
Int J Biol Markers; 2019 Sep; 34(3):309-317. PubMed ID: 31452437
[TBL] [Abstract][Full Text] [Related]
20. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Zhou H; He Y; Li L; Wu C; Hu G
Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
[No Abstract] [Full Text] [Related]
[Next] [New Search]